<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>BiotechVentureCapital | wechat-feeds</title><link>http://MzU5ODc2NTI1MA.favicon.privacyhide.com/favicon.ico</link><description>Biotech领域投资心得分享</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 19 May 2021 11:33:23 +0800</pubDate><image><url>http://MzU5ODc2NTI1MA.favicon.privacyhide.com/favicon.ico</url><title>BiotechVentureCapital | wechat-feeds</title><link>http://MzU5ODc2NTI1MA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>周末北大历史系学习随想</title><link>https://mp.weixin.qq.com/s/XmIBjrkx9-wGtqgmEgd-UA</link><description></description><content:encoded><![CDATA[周末北大历史系学习随想]]></content:encoded><pubDate>Wed, 19 May 2021 10:23:08 +0800</pubDate></item><item><title>​寻找中国生物医药投资的圣杯</title><link>https://mp.weixin.qq.com/s/I97-fs0yOb-3f15ZZwyAbw</link><description></description><content:encoded><![CDATA[​寻找中国生物医药投资的圣杯]]></content:encoded><pubDate>Fri, 26 Feb 2021 00:27:03 +0800</pubDate></item><item><title>不一样的新闻稿：优选为什么领投再极医药？</title><link>https://mp.weixin.qq.com/s/9nPSbhsaEmN0u3xsVNEZwQ</link><description></description><content:encoded><![CDATA[不一样的新闻稿：优选为什么领投再极医药？]]></content:encoded><pubDate>Tue, 05 Jan 2021 19:09:36 +0800</pubDate></item><item><title>CKD漫谈：How hard it can be？</title><link>https://mp.weixin.qq.com/s/4sdOW7kovgC-MD5QYeB2Pg</link><description></description><content:encoded><![CDATA[CKD漫谈：How hard it can be？]]></content:encoded><pubDate>Sun, 27 Dec 2020 18:48:43 +0800</pubDate></item><item><title>颠覆式创新：小分子PD-L1抑制剂能否破解PPI靶点成药难题？</title><link>https://mp.weixin.qq.com/s/gajrpLmqTSkABKdPboGF5g</link><description></description><content:encoded><![CDATA[颠覆式创新：小分子PD-L1抑制剂能否破解PPI靶点成药难题？]]></content:encoded><pubDate>Sun, 13 Dec 2020 23:44:32 +0800</pubDate></item><item><title>蓦然回首，灯火阑珊处</title><link>https://mp.weixin.qq.com/s/emQBY32juipldUqrKp60uA</link><description></description><content:encoded><![CDATA[蓦然回首，灯火阑珊处]]></content:encoded><pubDate>Wed, 09 Dec 2020 07:54:18 +0800</pubDate></item><item><title>不一样的CDK4/6抑制剂</title><link>https://mp.weixin.qq.com/s/l4iA9UVczPQeGlSlF9Jjmw</link><description></description><content:encoded><![CDATA[不一样的CDK4/6抑制剂]]></content:encoded><pubDate>Wed, 12 Aug 2020 08:54:20 +0800</pubDate></item><item><title>20位新药创始人：中国First in class新药的开发之路</title><link>https://mp.weixin.qq.com/s/9liLtdNnc4wPJ7Ir0UUH8A</link><description></description><content:encoded><![CDATA[20位新药创始人：中国First in class新药的开发之路]]></content:encoded><pubDate>Wed, 12 Aug 2020 08:54:20 +0800</pubDate></item><item><title>二代BTK开发热潮下的冷思考</title><link>https://mp.weixin.qq.com/s/HBU7D3o7c9jaScNb3qcH0Q</link><description></description><content:encoded><![CDATA[二代BTK开发热潮下的冷思考]]></content:encoded><pubDate>Tue, 30 Jun 2020 10:16:08 +0800</pubDate></item><item><title>相似的路,不同的结果</title><link>https://mp.weixin.qq.com/s/OEq-TWorT-AN0G-PiTKU2w</link><description></description><content:encoded><![CDATA[相似的路,不同的结果]]></content:encoded><pubDate>Thu, 11 Jun 2020 09:18:09 +0800</pubDate></item><item><title>​江苏新元素医药完成约3000万美金B轮融资</title><link>https://mp.weixin.qq.com/s/FMpoHX8yZzmOebWoTdUWqg</link><description></description><content:encoded><![CDATA[​江苏新元素医药完成约3000万美金B轮融资]]></content:encoded><pubDate>Wed, 27 May 2020 08:48:15 +0800</pubDate></item></channel></rss>